A Study of Stress Echocardiography in Post-Menopausal Women at Risk for Coronary Disease
Completed
Lantheus Medical Imaging
Phase 4
2004-04-01
The study is designed to see if stress echocardiography can be used as a screening exam in
peri-, or post-menopausal women with a risk of developing of coronary artery disease and
experiencing future cardiac events.
DMP115 in Patients With an Ejection Fraction Between 25%-40% to Evaluate the Use of Contrast Echocardiography to Assess Heart Function
Completed
Lantheus Medical Imaging
Phase 4
2006-07-01
The purpose of this clinical research study is to demonstrate the ability of Definity®
enhanced versus unenhanced cardiac ultrasound to improve the accuracy and reproducibility of
left ventricular ejection fraction (EF) when compared to magnetic resonance imaging (MRI).
Microbubble-Enhanced Clotbust Treatment of Acute Ischemic Stroke
Terminated
ImaRx Therapeutics
Phase 1/Phase 2
2005-03-01
The study is designed to examine the safety, tolerability, and activity of a combination of
microbubbles (perflutren lipid microsphere [Definity®]) and continuous monitoring with 2 MHz
transcranial Doppler ultrasound (TCD) as an adjunctive therapy to tissue plasminogen
activator (tPA) treatment in subjects with acute ischemic stroke.
Detection of Coronary Stenosis With Intravenous Microbubbles
Withdrawn
University of Nebraska
N/A
2012-02-01
To detect coronary artery disease by both coronary and carotid artery imaging and myocardial
perfusion imaging using a new low mechanical index real time system.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
